Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

$270 Million Drug Deal

A federal judge preliminarily approved a $270 million antitrust settlement Tuesday against Endo Pharmaceuticals, Teikoku Pharma and Actavis fka Watson Pharmaceuticals for colluding to prevent a generic form of the Lidoderm pain patch from reaching the market.

SAN FRANCISCO — A federal judge preliminarily approved a $270 million antitrust settlement Tuesday against Endo Pharmaceuticals, Teikoku Pharma and Actavis fka Watson Pharmaceuticals for colluding to prevent a generic form of the Lidoderm pain patch from reaching the market.

Categories / Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...